These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 15776118)

  • 1. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of heart failure in Canadian long-term care facilities.
    Heckman GA; Misiaszek B; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2004 Aug; 20(10):963-9. PubMed ID: 15332144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is a doctor to do...with digoxin?
    Pollak PT
    Can J Cardiol; 2005 Mar; 21(3):287-8. PubMed ID: 15776119
    [No Abstract]   [Full Text] [Related]  

  • 5. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
    Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
    Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversy in heart failure management: Digoxin use in the elderly.
    Chun J; Chodosh J
    J Am Med Dir Assoc; 2006 Nov; 7(9):581-6. PubMed ID: 17095423
    [No Abstract]   [Full Text] [Related]  

  • 9. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
    Cheng JW; Rybak I
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate use of digoxin in treating older nursing home patients with heart failure.
    Aronow WS
    J Am Med Dir Assoc; 2006 Nov; 7(9):604-6. PubMed ID: 17095428
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.
    Laguna P; Martn A; del Arco C; Gargantilla P;
    Ann Emerg Med; 2004 Jul; 44(1):3-11. PubMed ID: 15226703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of digoxin toxicity following hospitalization.
    Haynes K; Hennessy S; Localio AR; Cohen A; Leonard CE; Kimmel SE; Feldman HI; Strom BL; Metlay JP
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):28-35. PubMed ID: 19040200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of drug use in Jordan using WHO prescribing indicators.
    Otoom S; Batieha A; Hadidi H; Hasan M; Al-Saudi K
    East Mediterr Health J; 2002; 8(4-5):537-43. PubMed ID: 15603035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine prescribing and safety monitoring in patients with gout.
    Ly J; Gow P; Dalbeth N
    N Z Med J; 2007 Nov; 120(1265):U2808. PubMed ID: 18264188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin therapy for heart failure: an update.
    Morris SA; Hatcher HF; Reddy DK
    Am Fam Physician; 2006 Aug; 74(4):613-8. PubMed ID: 16939183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristics of digoxin utilization in a population under emergency care for heart failure or auricular fibrillation].
    Mundet X; Vidal X; Arnau JM
    Med Clin (Barc); 1993 Jan; 100(3):94-7. PubMed ID: 8426500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.